OX40-deficient mice are defective in Th cell proliferation but are competent in generating B cell and CTL responses after virus infection

Immunity

Volumn 11, Issue 6, 1999, Pages 699-708

  Kopf, Manfred ^a   Ruedl, Christiane ^a   Schmitz, Nicole ^a   Gallimore, Awen ^c   Lefrang, Karin ^a   Ecabert, Barbara ^a   Odermatt, Bernhard ^b   Bachmann, Martin F ^a  

^a BASEL INSTITUTE FOR IMMUNOLOGY   (Switzerland)

^b UNIVERSITY OF ZURICH   (Switzerland)

^c JOHN RADCLIFFE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; GAMMA INTERFERON; TUMOR NECROSIS FACTOR DERIVATIVE;

ANTIBODY RESPONSE; ARTICLE; B LYMPHOCYTE; CELL PROLIFERATION; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; GENE DISRUPTION; HELPER CELL; HUMORAL IMMUNITY; INFLUENZA VIRUS; LUNG LAVAGE; LYMPHOCYTE ACTIVATION; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MEMORY CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; VESICULAR STOMATITIS VIRUS; VIRUS INFECTION;

EID: 0033427047     PISSN: 10747613     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1074-7613(00)80144-2     Document Type: Article

References (50)

1. Al-Shamkhani, A., Birkeland, M.L., Puklavec, M., Brown, M.H., James, W., and Barclay, A.N. (1996). OX40 is differentially expressed on activated rat and mouse T cells and is the sole receptor for the OX40 ligand. Eur. J. Immunol. 26, 1695-1699.
2. Altman, J.D., Moss, P.A.H., Goulder, P.J.R., Barouch, D.H., McHeyzer-Williams, M.G., Bell, J.I., McMichael, A.J., and Davis, M.M. (1996). Phenotypic analysis of antigen-specific T lymphocytes. Science 274, 94-96. Erratum: Science 280(5371), 1998.
3. Anderson, D.M., Maraskovsky, E., Billingsley, W.L., Dougall, W.C., Tometsko, M.E., Roux, E.R., Teepe, M.C., DuBose, R.F., Cosman, D., and Galibert, L. (1997). A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function. Nature 390, 175-179.
4. Bachmann, M.F. (1997). Evaluation of lymphocytic choriomeningitis virus-specific cytotoxic T cell responses. In Immunology Methods Manual, I. Lefkovits, ed. (New York: Academic Press), pp. 1921-1933.
5. Bachmann, M.F., and Zinkernagel, R.M. (1997). Neutralizing antiviral B cell responses. Annu. Rev. Immunol. 15, 235-270.
6. Bachmann, M.F., Odermatt, B., Hengartner, H., and Zinkernagel, R.M. (1996). Induction of long-lived germinal centers associated with persisting antigen after viral infection. J. Exp. Med. 183, 2259-2269.
7. Bachmann, M.F., Kalinke, U., Althage, A., Freer, G., Burkhart, C., Roost, H.-P., Aguet, M., Hengartner, H., and Zinkernagel, R.M. (1997). The roles of antibody concentration and avidity in anti-viral protection. Science 276, 2024-2027.
8. Bachmann, M.F., Wong, B.R., Josien, R., Steinman, R.M., Oxenius, A., and Choi, Y. (1999a). Trance, a TNF family member critical for CD40-independent T helper cell activation. J. Exp. Med. 189, 1025-1031.
9. Bachmann, M.F., Ecabert, B., and Kopf, M. (1999b). Influenza virus: A novel method to assess viral and neutralizing antibody titers in vitro. J. Immunol. Methods 225, 105-111.
10. Baker, S.J., and Reddy, E.P. (1996). Transducers of life and death: TNF receptor superfamily and associated proteins. Oncogene 12, 1-9.
11. Battegay, M., Moskophidis, D., Waldner, H., Brundler, M.A., Fung-Leung, W.P., Mak, T.W., Hengartner, H., and Zinkernagel, R.M. (1993). Impairment and delay of neutralizing antiviral antibody responses by virus-specific cytotoxic T cells. J. Immunol. 151, 5408-5415. Erratum: J. Immunol. 151(5), 1994.
12. Baum, P.R., Gayle, R.B., 3rd, Ramsdell, F., Srinivasan, S., Sorensen, R.A., Watson, M.L., Seldin, M.F., Baker, E., Sutherland, G.R., Clifford, K.N., et al. (1994). Molecular characterization of murine and human OX40/OX40 ligand systems: Identification of a human OX40 ligand as the HTLV-1-regulated protein gp34. EMBO J. 13, 3992-4001.
13. Borrow, P., Tishon, A., Lee, S., Xu, J., Grewal, I.S., Oldstone, M.B., and Flavell, R.A. (1996). CD40L-deficient mice show deficits in antiviral immunity and have an impaired memory CD8+ CTL response. J. Exp. Med. 183, 2129-2142.
14. Brocker, T., Gulbranson-Judge, A., Flynn, S., Riedinger, M., Raykundalia, C., and Lane, P. (1999). CD4 T cell traffic control: In vivo evidence that ligation of OX40 on CD4 T cells by OX40-ligand expressed on dendritic cells leads to the accumulation of CD4 T cells in B follicles. Eur. J. Immunol. 29, 1610-1616.
15. Calderhead, D.M., Buhlmann, J.E., van den Eertwegh, A.J., Claassen, E., Noelle, R.J., and Fell, H.P. (1993). Cloning of mouse Ox40: A T cell activation marker that may mediate T-B cell interactions. J. Immunol. 151, 5261-5271.
16. Charan, S., Hengartner, H., and Zinkernagel, R.M. (1986). Primary antibody responses to a well-defined and unique hapten are not enhanced by preimmunization with carrier: Analysis in a viral model. Proc. Natl. Acad. Sci. USA 83, 2604-2608.
17. DeBenedette, M.A., Wen, T., Bachmann, M.F., Ohashi, P., Barber, B.H., Stocking, K.L., Peschon, J., and Watts, T.H. (1999). Analysis of 4-1BB ligand-deficient mice and of mice lacking both 4-1BB ligand and CD28 reveals a role for 4-1BB ligand in skin allograft rejection and the cytotoxic T cell response to influenza virus. J. Immunol. 163, 4833-4841.
18. + T-cell mechanisms in the control of respiratory virus infections. Immunol. Rev. 159, 105-117.
19. Flynn, S., Toellner, K.M., Raykundalia, C., Goodall, M., and Lane, P. (1998). CD4 T cell cytokine differentiation: The B cell activation molecule, OX40 ligand, instructs CD4 T cells to express interleukin 4 and upregulates expression of the chemokine receptor, Blr-1. J. Exp. Med. 188, 297-304.
20. Foy, T.M., Aruffo, A., Bajorah, J., Buhlmann, J.E., and Noelle, J.N. (1996). Immune regulation by CD40 and its ligand. Annu. Rev. Immunol. 14, 591-617.
21. Gallimore, A., Glithero, A., Godkin, A., Tissot, A.C., Pluckthun, A., Elliott, T., Hengartner, H., and Zinkernagel, R. (1998). Induction and exhaustion of lymphocytic choriomeningitis virus-specific cytotoxic T lymphocytes visualized using soluble tetrameric major histocompatibility complex class I-peptide complexes. J. Exp. Med. 187, 1383-1393.
22. Gause, W.C., Chen, S.J., Greenwald, R.J., Halvorson, M.J., Lu, P., Zhou, X.D., Morris, S.C., Lee, K.P., June, C.H., Finkelman, F.D., et al. (1997). CD28 dependence of T cell differentiation to IL-4 production varies with the particular type 2 immune response. J. Immunol. 158, 4082-4087.
23. Gramaglia, I., Weinberg, A.D., Lemon, M., and Croft, M. (1998). Ox40 ligand: A potent costimulatory molecule for sustaining primary CD4 T cell responses. J. Immunol. 161, 6510-6517.
24. Gravestein, L.A., and Borst, J. (1998). Tumor necrosis factor receptor family members in the immune system. Semin. Immunol. 10, 423-434.
25. Gray, D., Kosco, M., and Stockinger, B. (1991). Novel pathways of antigen presentation for the maintenance of memory. Int. Immunol. 3, 141-148.
26. Grewal, I.S., and Flavell, R.A. (1998). CD40 and CD154 in cell-mediated immunity. Annu. Rev. Immunol. 16, 111-136.
27. Higgins, L.M., McDonald, S.A., Whittle, N., Crockett, N., Shields, J.G., and MacDonald, T.T. (1999). Regulation of T cell activation in vitro and in vivo by targeting the OX40-OX40 ligand interaction: Amelioration of ongoing inflammatory bowel disease with an OX40-IgG fusion protein, but not with an OX40 ligand-IgG fusion protein. J. Immunol. 162, 486-493.
28. Imura, A., Hori, T., Imada, K., Ishikawa, T., Tanaka, Y., Maeda, M., Imamura, S., and Uchiyama, T. (1996). The human OX40/gp34 system directly mediates adhesion of activated T cells to vascular endothelial cells. J. Exp. Med. 183, 2185-2195.
29. Kawai, K., Shahinian, A., Mak, T.W., and Ohashi, P.S. (1996). Skin allograft rejection in CD28-deficient mice. Transplantation 61, 352-355.
30. Kawamata, S., Hori, T., Imura, A., Takaori-Kondo, A., and Uchiyama, T. (1998). Activation of OX40 signal transduction pathways leads to tumor necrosis factor receptor-associated factor (TRAF) 2- and TRAF5-mediated NF-κB activation. J. Biol. Chem. 273, 5808-5814.
31. Kopf, M. (1996). Protocols for gene targeting. In Immunology Methods Manual: The Comprehensive Sourcebook of Techniques, I. Lefkovits, ed. (San Diego, CA: Academic Press), pp. 199-216.
32. Kopf, M., Brombacher, F., Kohler, G., Kienzle, G., Widmann, K.H., Lefrang, K., Humborg, C., Ledermann, B., and Solbach, W. (1996). IL-4-deficient Balb/c mice resist infection with Leishmania major. J. Exp. Med. 184, 1127-1136.
33. Kündig, T.M., Shahinian, A., Kawai, K., Mittrücker, H.-W., Sebzda, E., Bachmann, M.F., Mak, T.W., and Ohashi, P.S. (1996). Duration of TCR stimulation determines costimulatory requirement of T cells. Immunity 5, 41-52.
34. Lenschow, D.J., Walunas, T.L., and Bluestone, J.A. (1996). CD28/B7 system of T cell costimulation. Annu. Rev. Immunol. 14, 233-258.
35. Ohshima, Y., Tanaka, Y., Tozawa, H., Takahashi, Y., Maliszewski, C., and Delespesse, G. (1997). Expression and function of OX40 ligand on human dendritic cells. J. Immunol. 159, 3838-3848.
36. Ohshima, Y., Yang, L.P., Uchiyama, T., Tanaka, Y., Baum, P., Sergerie, M., Hermann, P., and Delespesse, G. (1998). OX40 costimulation enhances interleukin-4 (IL-4) expression at priming and promotes the differentiation of naive human CD4(+) T cells into high IL-4-producing effectors. Blood 92, 3338-3345.
37. + T cell functions. J. Exp. Med. 183, 2209-2218.
38. Paterson, D.J., Jefferies, W.A., Green, J.R., Brandon, M.R., Corthesy, P., Puklavec, M., and Williams, A.F. (1987). Antigens of activated rat T lymphocytes including a molecule of 50,000 Mr detected only on CD4 positive T blasts. Mol. Immunol. 24, 1281-1290.
39. Shahinian, A., Pfeffer, K., Lee, K.P., Kündig, T.M., Ohashi, P.S., Thompson, C.B., and Mak, T.W. (1993). Differential T cell costimulatory requirements in CD28-deficient mice. Science 261, 609-612.
40. + T cell proliferation and lead to the amplification in vivo of cytotoxic T cell responses. J. Exp. Med. 186, 47-55.
41. Stuber, E., and Strober, W. (1996). The T cell-B cell interaction via OX40-OX40L is necessary for the T cell-dependent humoral immune response. J. Exp. Med. 183, 979-989.
42. Stuber, E., Neurath, M., Calderhead, D., Fell, H.P., and Strober, W. (1995). Cross-linking of OX40 ligand, a member of the TNF/NGF cytokine family, induces proliferation and differentiation in murine splenic cells. Immunity 2, 507-521.
43. Takahashi, C., Mittler, R.S., and Vella, A.T. (1999). Cutting edge: 4-1BB is a bona fide CD8 T cell survival signal. J. Immunol. 162, 5037-5040.
44. Tuosto, L., and Acuto, O. (1998). CD28 affects the earliest signaling events generated by TCR engagement. Eur. J. Immunol. 28, 2131-2142.
45. Vinay, D.S., and Kwon, B.S. (1998). Role of 4-1BB in immune responses. Semin. Immunol. 10, 481-489.
46. Watts, T.H., and DeBenedette, M.A. (1999). T cell co-stimulatory molecules other than CD28. Curr. Opin. Immunol. 11, 286-293.
47. Weinberg, A.D., Bourdette, D.N., Sullivan, T.J., Lemon, M., Wallin, J.J., Maziarz, R., Davey, M., Palida, F., Godfrey, W., Engleman, E., et al. (1996). Selective depletion of myelin-reactive T cells with the anti-OX-40 antibody ameliorates autoimmune encephalomyelitis. Nat. Med. 2, 183-189.
48. Weinberg, A.D., Vella, A.T., and Croft, M. (1998). OX-40: Life beyond the effector T cell stage. Semin. Immunol. 10, 471-480.
49. Whitmire, J.K., Slifka, M.K., Grewal, I.S., Flavell, R.A., and Ahmed, R. (1996). CD40 ligand-deficient mice generate a normal primary cytotoxic T-lymphocyte response but a defective humoral response to a viral infection. J. Virol. 70, 8375-8381.
50. Wong, B.R., Josien, R., Lee, S.Y., Sauter, B., Li, H.L., Steinman, R.M., and Choi, Y. (1997). Trance (tumor necrosis factor [TNF]-related activation-induced cytokine), a new TNF family member predominantly expressed in T cells, is a dendritic cell-specific survival factor. J. Exp. Med. 186, 2075-2080.